Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, today announced the appointment of Douglas Manion, M.D., FRCP (C), as Chief Executive ...
read more
Wednesday, August 15, 2018
Mundipharma and Helsinn Group signed a licensing and distribution agreement for the anti-emetic agent Aloxi in Vietnam, extending an international collaboration.
read more
KBI Biopharma, Inc. (KBI) has signed an agreement with Merck & Co., Inc. (known as Merck in the United States and Canada) to acquire Merck’s microbial process development and manufacturing operations in Boulder, Colorado, effective May 1, 2014. Under...
read more
Friday, February 08, 2019
Torque and Thermo Fisher Scientific announced a collaboration to build a dedicated Slipstream manufacturing facility for high-efficiency production of Torque's Deep-Primed T cell immunotherapies.
read more
BioClinica®, Inc., a global provider of clinical trial management solutions, announced today the introduction of StudyView™, a clinical trials portal and reporting hub that dramatically increases clinical trials operational visibility. StudyView ...
read more
Aesica, the global pharmaceutical contract development and manufacturing organisation (CDMO), has today announced it has successfully introduced serialisation services and initiated commercial production of two anti-allergy product lines for the ...
read more
WuXi AppTec, an open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, has acquired Crelux GmbH, a structure based drug discovery provider based in Munich, Germany.
read more
Pharmaceutical Product Development announced it added two new leaders in product development.
read more
Pulmatrix and Cipla announced their entry into a Definitive Agreement for the co-development and commercialization of Pulmazole™, an inhaled iSPERSE™ formulation of the anti-fungal drug itraconazole.
read more
Wednesday, March 23, 2016
Diversigen a provider of comprehensive microbiome analysis services, has announced a strategic partnership with BioCore Co. Ltd., a bioanalytical contract research organization, based in Seoul, South Korea.
read more
Elligo Health Research has announced its partnership with N. Harris Computer Corporation through its Sidus Insights, Inc. subsidiary.
read more
AMRI, a leading global contract research and manufacturing organization, announced today the appointment of Ian Shott as President of AMRI Europe, reporting to Thomas D’Ambra, Ph.D., chairman, president and CEO. In this newly created role, Mr. Shott ...
read more
Albany, NY (April 23, 2013) — AMRI announced today that it has entered into a new five-year service agreement with Ono Pharmaceutical Company, Ltd., (TSE: 4528), a pharmaceutical company headquartered in Osaka, Japan. Under the terms of the agreement...
read more
WIRB-Copernicus Group®, a provider of solutions that measurably improve the quality and efficiency of clinical research, has announced its acquisition of CenterWatch, a provider of clinical trial industry news and information, and the addition of ...
read more
Nexus Pharmaceuticals announced that its pharmaceutical manufacturing facility in Pleasant Prairie, Wisconsin, was successfully inspected by the FDA, which will allow Nexus to begin commercial operations.
read more